Dubai, UAE – January, 2025
Fusion Inc., a Japan-based leader in integrative health solutions, successfully participated in Arab Health 2025, unveiling its flagship brand LIFEXP to the Middle Eastern market. The company’s presence at the region’s largest healthcare exhibition highlighted its commitment to scientifically backed, clean-label nutraceuticals and its dedication to advancing precision-integrative care.
LIFEXP products, developed in GMP-certified Japanese facilities, were met with strong interest among regional healthcare professionals, distributors, and institutional partners. Focus areas included vision health, neuroinflammatory regulation, and connective tissue-based longevity solutions.
“We are here to build real partnerships in health transformation,” said Dr. Guzel Bikbova, Founder of Fusion Inc. “Arab Health 2025 is not just about showcasing products — it’s about aligning clinical insight with local health priorities and building a bridge between science, ethics, and accessibility.”
Strategic Discussions & Expansion Plans
Fusion Inc. engaged in multiple strategic meetings with hospitals, pharmacies, and government health representatives from the UAE, Saudi Arabia, and Qatar. Talks focused on:
A Vision for Ethical Innovation
LIFEXP, already known for its advanced formulations such as VisionGuardPro, NeuroVision+, and VertiCalm XP, continues to lead in clean, evidence-based supplementation. Its terrain-informed formulations are rooted in Japanese manufacturing excellence, functional medicine research, and deep clinical insight.
Looking Ahead
Fusion Inc. plans to formalize new partnerships in the region by Q3 2025 and launch a dedicated education and professional outreach platform for Arabic-speaking practitioners through the LIFEXP Institute.
Media Contact:
Yasmin Akhmetova
Communications Director, Fusion Inc.
Email: info@lifexp-japan.com
Fusion Inc., a Japan-based leader in integrative health solutions, successfully participated in Arab Health 2025, unveiling its flagship brand LIFEXP to the Middle Eastern market. The company’s presence at the region’s largest healthcare exhibition highlighted its commitment to scientifically backed, clean-label nutraceuticals and its dedication to advancing precision-integrative care.
LIFEXP products, developed in GMP-certified Japanese facilities, were met with strong interest among regional healthcare professionals, distributors, and institutional partners. Focus areas included vision health, neuroinflammatory regulation, and connective tissue-based longevity solutions.
“We are here to build real partnerships in health transformation,” said Dr. Guzel Bikbova, Founder of Fusion Inc. “Arab Health 2025 is not just about showcasing products — it’s about aligning clinical insight with local health priorities and building a bridge between science, ethics, and accessibility.”
Strategic Discussions & Expansion Plans
Fusion Inc. engaged in multiple strategic meetings with hospitals, pharmacies, and government health representatives from the UAE, Saudi Arabia, and Qatar. Talks focused on:
- Clinical training programs in integrative ophthalmology
- Regional clinical collaborations and product customization
- Local distribution partnerships for the MENA market
A Vision for Ethical Innovation
LIFEXP, already known for its advanced formulations such as VisionGuardPro, NeuroVision+, and VertiCalm XP, continues to lead in clean, evidence-based supplementation. Its terrain-informed formulations are rooted in Japanese manufacturing excellence, functional medicine research, and deep clinical insight.
Looking Ahead
Fusion Inc. plans to formalize new partnerships in the region by Q3 2025 and launch a dedicated education and professional outreach platform for Arabic-speaking practitioners through the LIFEXP Institute.
Media Contact:
Yasmin Akhmetova
Communications Director, Fusion Inc.
Email: info@lifexp-japan.com
